Fibrolyse

Fibrolyse refers to the breakdown or dissolution of fibrous tissue. This process is often associated with medical treatments aimed at reducing or eliminating scar tissue, adhesions, or fibrotic conditions. In some contexts, fibrolyse might refer to a natural biological process where the body breaks down excess or damaged fibrous material.

Therapeutic fibrolyse can be achieved through various methods. These may include the use of enzymes, pharmacological agents, or physical interventions. For example, certain enzymatic injections are used to target and break down scar tissue, which can improve flexibility and reduce pain. In the management of keloids or hypertrophic scars, treatments designed to induce fibrolyse aim to flatten and soften the raised scar tissue.

Adhesions, bands of scar tissue that can form after surgery or injury, can also be targeted by fibrolytic therapies. The goal is to dissolve these adhesions, preventing them from restricting organ movement or causing pain. Fibrotic diseases, such as liver cirrhosis or pulmonary fibrosis, involve excessive buildup of fibrous tissue, and research into fibrolytic treatments is ongoing for these conditions, though their application is more complex and experimental. The concept of fibrolyse underscores the dynamic nature of connective tissue and the potential to modulate its excessive formation or persistence.